The Optispan Podcast with Matt Kaeberlein cover image

Inside the Offshore Clinics Developing Gene Therapy to Fight Aging | 125

The Optispan Podcast with Matt Kaeberlein

00:00

Cost, scaling, and future accessibility

They discuss manufacturing costs for plasmid versus AAV, scale economics, and visions for affordable widespread access.

Play episode from 01:44:04
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app